查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024442

細胞檢測市場報告：按產品/服務、技術、應用、最終用戶和地區分類（2026-2034 年）

Cell-based Assay Market Report by Product and Services, Technology, Application, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球細胞檢測市場規模達257億美元。預計到2034年，該市場規模將達到466億美元，2026年至2034年的複合年成長率（CAGR）為6.61%。推動該市場成長的主要因素是市場對先進藥物研發解決方案的需求不斷成長，尤其是慢性病盛行率上升以及對標靶治療的需求。對個人化醫療的日益重視，以及3D細胞培養和高通量篩檢技術的創新，正在加速細胞檢測技術的應用。此外，這些檢測技術能夠增強早期毒性預測並簡化藥物研發流程，因此吸引了大量投資，並進一步擴大了細胞檢測技術的市場佔有率。

細胞分析（也稱為細胞檢測）是一種實驗技術，廣泛應用於科學和醫學領域，用於評估細胞對特定物質或條件的生物活性反應。該技術包括在受控環境中培養活細胞，並將其暴露於各種刺激物，例如藥物、化合物或環境因素。由於監測細胞行為的變化（例如細胞活力和特定生物標記的表達）能夠深入了解測試物質對細胞功能的影響，因此全球對細胞分析的需求正在不斷成長。

目前，細胞檢測技術在藥物發現、毒理學研究、疾病建模和細胞機制闡明等領域的日益普及，正在推動該市場的成長。此外，評估藥物化合物潛在療效和安全性的需求不斷成長，也促進了市場發展。而且，在研發早期階段識別潛在不良反應並評估化學物質毒性的能力，增加了對細胞檢測技術的需求，這對市場產生了積極影響。此外，包括癌症、糖尿病和自體免疫疾病在內的多種慢性疾病在全球範圍內的日益流行，為該行業的投資者創造了極具吸引力的成長機會。最後，評估化學物質和污染物對植物和水生生態系統影響的需求不斷成長，也推動了市場成長。

細胞檢測市場的趨勢與促進因素：

對治療各種疾病的新治療方法的需求日益成長

全球對藥物發現和研發的日益重視，以及對治療各種慢性疾病的新治療方法的需求不斷成長，共同推動了市場成長。此外，基於細胞的檢測方法使研究人員能夠快速且有效率地篩檢和評估大量潛在候選藥物。透過將細胞暴露於各種化合物，科學家可以評估這些化合物對細胞行為的影響，包括其療效和安全性。此外，精準醫療的日益普及（精準醫療需要深入了解藥物如何與特定細胞路徑相互作用）也為基於細胞的檢測市場帶來了光明的前景。而且，這些檢測方法也提供了一個平台，可以根據個別患者的具體情況最佳化藥物治療方案。

人們越來越關注個人化醫療

公眾對個人化醫療日益成長的興趣正在推動市場成長。因此，醫療機構正迅速將重點放在根據患者的基因、分子和細胞特徵量身定做的治療方案上。此外，基於細胞的檢測方法使研究人員能夠評估患者來源細胞對各種藥物和療法的反應，從而幫助他們找到最有效的治療方法，同時最大限度地減少潛在的副作用。根據細胞檢測的市場調查報告，個人化醫療不僅能改善治療效果，還能透過避免無效治療來降低醫療成本。因此，細胞檢測作為一種強大的工具，擴大應用於臨床和研究領域，以最佳化醫療干預措施，滿足特定患者的需求。

細胞培養技術的創新

細胞培養技術的進步正在增強基於細胞的檢測方法的能力。 3D培養和類器官技術使研究人員能夠在接近人體的條件下研究細胞行為，從而提高藥物篩檢和毒性測試的準確性。這為市場帶來了光明的前景。此外，微流體和實驗室晶片技術能夠開發小型化和自動化的基於細胞的檢測方法，有助於提高藥物發現的通量和效率。因此，將這些先進的細胞培養技術整合到基於細胞的檢測方法中，可以增強其相關性和適用性，使其成為闡明疾病機制和更精確地評估候選藥物的理想工具。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球細胞檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依產品和服務分類
  • 市場區隔：依技術分類
  • 市場區隔：按應用領域
  • 市場區隔：依最終用戶分類
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
  • 價值鏈分析
  • 波特五力分析

第6章 市場區隔：依產品及服務分類

  • 消耗品
    • 試劑和培養基
    • 細胞和細胞株
    • 探針和標籤
  • 裝置
    • 微孔盤
    • 微孔盤讀數儀
    • 高通量篩檢
    • 液體處理系統
  • 服務
  • 軟體

第7章 市場區隔：依技術分類

  • 自動化運輸
  • 流式細胞技術
  • 無標定檢測
  • 高通量篩檢
  • 其他

第8章 市場區隔：依應用領域分類

  • 藥物發現
  • 基本調查
  • ADME 研究
  • 預測毒理學
  • 其他

第9章 市場區隔：依最終用戶分類

  • 製藥和生物技術公司
  • 學術機構及政府機構
  • 受託研究機構
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第11章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories, Inc
    • Cell Biolabs, Inc.
    • Cell Signaling Technology, Inc
    • Charles River Laboratories
    • Corning Incorporated
    • DH Life Sciences, LLC
    • Eurofins DiscoverX
    • Lonza
    • Merck KGaA
    • Promega Corporation
    • Thermo Fisher Scientific Inc
Product Code: SR112026A1079

The global cell-based assay market size reached USD 25.7 Billion in 2025. Looking forward, the market is projected to reach USD 46.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.61% during 2026-2034. The market is driven by the growing demand for advanced drug discovery solutions, particularly in the context of rising chronic disease prevalence and the need for targeted therapies. Increasing emphasis on personalized medicine, coupled with innovations in 3D cell cultures and high-throughput screening technologies, is accelerating the adoption of cell-based assays. Additionally, the ability of these assays to enhance early-stage toxicity prediction and streamline pharmaceutical R&D is drawing substantial investment, further augmenting the cell-based assay market share.

A cell-based assay, also known as a cellular assay, is a laboratory technique that is used in various scientific and medical fields to assess the biological activity of cells in response to specific substances or conditions. It comprises culturing living cells in controlled environments and exposing them to various stimuli, such as drugs, compounds, or environmental factors. As it allows researchers to gain critical insights into the effects of the tested substances on cellular function by monitoring changes in cell behavior, such as cell viability or the expression of specific biomarkers, the demand for cell-based assay is increasing worldwide.

At present, the rising adoption of cell-based assays for drug discovery, toxicology studies, disease modeling, and understanding cellular mechanisms is supporting the cell-based assay market growth. Besides this, the increasing need to evaluate the potential efficacy and safety of pharmaceutical compounds is strengthening the growth of the market. Additionally, the growing demand for cell-based assays, as they enable researchers to identify potential adverse effects early in the development process and assess the toxicity of chemicals, is positively influencing the market. Apart from this, increasing incidences of numerous chronic diseases, such as cancer, diabetes, and autoimmune disorders, among individuals around the world are offering lucrative growth opportunities to industry investors. Furthermore, the rising need to assess the impact of chemicals and pollutants on plant and aquatic systems is bolstering the growth of the market.

CELL-BASED ASSAY MARKET TRENDS/DRIVERS:

Rising demand for novel therapies to address various diseases

The rising focus on drug discovery and development, along with the increasing demand for novel therapies to address various chronic diseases among individuals across the globe, is contributing to the growth of the market. In addition, cell-based assays enable researchers to screen and evaluate a vast number of potential drug candidates quickly and efficiently. By exposing cells to different compounds, scientists can assess their impact on cellular behavior, including their efficacy and safety profiles. Apart from this, there is an increase in the focus on precision medicine that necessitates a deep understanding of how drugs interact with specific cellular pathways, thereby creating a positive cell-based assay market outlook. Moreover, these assays provide a platform for tailoring drug treatments to individual patient profiles.

Increasing focus on personalized medicines

The rising focus on personalized medicines among the masses is supporting the growth of the market. In line with this, healthcare facilities are rapidly focusing on treatment solutions that are customized to suit the genetic, molecular, and cellular characteristics of individual patients. Besides this, cell-based assays allow researchers to evaluate the response of patient-derived cells to various drugs and treatments and enable the identification of the most effective therapies while minimizing potential side effects. According to the cell-based assay market research report, personalized medicine not only improves treatment outcomes but also reduces healthcare costs by avoiding ineffective treatments. As a result, there is an increase in the adoption of cell-based assays in both clinical and research settings, as they provide a powerful tool for tailoring medical interventions to the specific needs of patients.

Innovations in cell culture technologies

Advancements in cell culture techniques are enhancing the capabilities of cell-based assays. 3D cultures and organoids allow researchers to study cell behavior closer to the human body to improve the accuracy of drug screening and toxicity testing, which is offering a positive market outlook. Additionally, microfluidics and lab-on-a-chip technologies enable the development of miniaturized and automated cell-based assays that assist in increasing throughput and efficiency in drug discovery. In line with this, the integration of these advanced cell culture technologies into cell-based assays aids in enhancing their relevance and applicability, which makes them suitable tools for understanding disease mechanisms and evaluating drug candidates with greater precision.

CELL-BASED ASSAY INDUSTRY SEGMENTATION:

Breakup by Product and Services:

  • Consumables
    • Reagents and Media
    • Cells and Cell Lines
    • Probes and Labels
  • Instruments
    • Microplates
    • Microplate Readers
    • High Throughput Screening
    • Liquid Handling Systems
  • Services
  • Software

Consumables represent the largest market segment

Breakup by Technology:

  • Automated Handling
  • Flow Cytometry
  • Label-Free Detection
  • High-Throughput Screening
  • Others

High-throughput screening accounts for the majority of the market share

Breakup by Application:

  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Others

Drug discovery dominates the market share

Breakup by End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutions
  • Contract Research Organizations
  • Others

Pharmaceutical and biotechnology companies hold the biggest market share

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest cell-based assay market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increasing demand for advanced assay technologies and consumables. In addition, the rising development of novel cell-based assay techniques is bolstering the growth of the market in the region. Apart from this, the growing focus on drug safety is positively influencing the market. In line with this, stringent regulatory standards are propelling the growth of the market in the North America region.

COMPETITIVE LANDSCAPE:

Major players are developing innovative assay technologies, such as novel reagents, assay kits, and platforms. This involves creating more physiologically relevant cell models to improve assay sensitivity and enhance automation and data analysis capabilities. In line with this, companies are expanding their product portfolios to cater to a wide range of applications. This includes offering assays tailored for specific targets, pathways, or disease models, and developing specialized kits for toxicity testing and drug screening. Apart from this, key manufacturers are providing customized assay development services and are working closely with clients to tailor assays to their specific research needs, which is offering a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc
  • Charles River Laboratories
  • Corning Incorporated
  • DH Life Sciences, LLC
  • Eurofins DiscoverX
  • Lonza
  • Merck KGaA
  • Promega Corporation
  • Thermo Fisher Scientific Inc

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell-Based Assay Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Services
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product and Services

  • 6.1 Consumables
    • 6.1.1 Reagents and Media
      • 6.1.1.1 Market Trends
      • 6.1.1.2 Market Forecast
    • 6.1.2 Cells and Cell Lines
      • 6.1.2.1 Market Trends
      • 6.1.2.2 Market Forecast
    • 6.1.3 Probes and Labels
      • 6.1.3.1 Market Trends
      • 6.1.3.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Microplates
      • 6.2.1.1 Market Trends
      • 6.2.1.2 Market Forecast
    • 6.2.2 Microplate Readers
      • 6.2.2.1 Market Trends
      • 6.2.2.2 Market Forecast
    • 6.2.3 High Throughput Screening
      • 6.2.3.1 Market Trends
      • 6.2.3.2 Market Forecast
    • 6.2.4 Liquid Handling Systems
      • 6.2.4.1 Market Trends
      • 6.2.4.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Automated Handling
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Flow Cytometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Label-Free Detection
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 High-Throughput Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Basic Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 ADME Studies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Predictive Toxicology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Government Institutions
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Beckman Coulter, Inc.
    • 11.3.2 Bio-Rad Laboratories, Inc
    • 11.3.3 Cell Biolabs, Inc.
    • 11.3.4 Cell Signaling Technology, Inc
    • 11.3.5 Charles River Laboratories
    • 11.3.6 Corning Incorporated
    • 11.3.7 DH Life Sciences, LLC
    • 11.3.8 Eurofins DiscoverX
    • 11.3.9 Lonza
    • 11.3.10 Merck KGaA
    • 11.3.11 Promega Corporation
    • 11.3.12 Thermo Fisher Scientific Inc

List of Figures

  • Figure 1: Global: Cell-Based Assay Market: Major Drivers and Challenges
  • Figure 2: Global: Cell-Based Assay Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cell-Based Assay Market: Breakup by Product and Services (in %), 2025
  • Figure 4: Global: Cell-Based Assay Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Cell-Based Assay Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Cell-Based Assay Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Cell-Based Assay Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Cell-Based Assay Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Cell-Based Assay Industry: SWOT Analysis
  • Figure 10: Global: Cell-Based Assay Industry: Value Chain Analysis
  • Figure 11: Global: Cell-Based Assay Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Cell-Based Assay (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Cell-Based Assay (Consumables- Reagents and Media) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Cell-Based Assay (Consumables- Reagents and Media) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Cell-Based Assay (Consumables- Probes and Labels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Cell-Based Assay (Consumables- Probes and Labels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Cell-Based Assay (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Cell-Based Assay (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Cell-Based Assay (Instruments-Microplates) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Cell-Based Assay (Instruments-Microplates) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Cell-Based Assay (Instruments-Microplate Readers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Cell-Based Assay (Instruments- Microplate Readers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Cell-Based Assay (Instruments-High Throughput Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Cell-Based Assay (Instruments- High Throughput Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Cell-Based Assay (Instruments- Liquid Handling Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Cell-Based Assay (Instruments-Liquid Handling Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Cell-Based Assay (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Cell-Based Assay (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Cell-Based Assay (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Cell-Based Assay (Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Cell-Based Assay (Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Cell-Based Assay (Automated Handling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Cell-Based Assay (Automated Handling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Cell-Based Assay (Flow Cytometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Cell-Based Assay (Flow Cytometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Cell-Based Assay (Label-Free Detection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Cell-Based Assay (Label-Free Detection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Cell-Based Assay (High-Throughput Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Cell-Based Assay (High-Throughput Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Cell-Based Assay (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Cell-Based Assay (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: Cell-Based Assay (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: Cell-Based Assay (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: Cell-Based Assay (Basic Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Global: Cell-Based Assay (Basic Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Global: Cell-Based Assay (ADME Studies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Global: Cell-Based Assay (ADME Studies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Global: Cell-Based Assay (Predictive Toxicology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Global: Cell-Based Assay (Predictive Toxicology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Global: Cell-Based Assay (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Global: Cell-Based Assay (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Global: Cell-Based Assay (Academic and Government Institutions) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Global: Cell-Based Assay (Academic and Government Institutions) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Global: Cell-Based Assay (Contract Research Organizations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Global: Cell-Based Assay (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Global: Cell-Based Assay (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Global: Cell-Based Assay (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: North America: Cell-Based Assay Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: North America: Cell-Based Assay Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Europe: Cell-Based Assay Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Europe: Cell-Based Assay Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Asia Pacific: Cell-Based Assay Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Asia Pacific: Cell-Based Assay Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Middle East and Africa: Cell-Based Assay Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Middle East and Africa: Cell-Based Assay Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Cell-Based Assay Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Cell-Based Assay Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Cell-Based Assay Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cell-Based Assay Market Forecast: Breakup by Product and Services (in Million USD), 2026-2034
  • Table 3: Global: Cell-Based Assay Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Cell-Based Assay Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Cell-Based Assay Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Cell-Based Assay Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Cell-Based Assay Market: Competitive Structure
  • Table 8: Global: Cell-Based Assay Market: Key Players